FDA: Genetically modified salmon may be approved in 2013

Digital Journal | May 7, 2013

By Igor I. Solar

The US-Food and Drug Administration has completed the phase of public consultation prior to making a decision on allowing commercial production of AquaBounty’s genetically modified salmon and the fish going to market for human consumption.

In 2010, the United States Food and Drug Administration (FDA) said that AquaBounty’s genetically modified salmon (GM salmon; AquAdvantage Salmon) is safe to eat. In 2012, the FDA released a “Draft Environmental Assessment” (EA) and a “Preliminary Finding of No Significant Impact” (FONSI) in connection with the potential environmental impact of GM salmon. Both documents contain a “no effect” determination. The FDA says in its assessment:
“…The AquAdvantage Salmon will not jeopardize the continued existence of United States populations of threatened or endangered Atlantic salmon, or result in the destruction or adverse modification of their critical habitat, when produced and reared under the conditions described…” “FDA has carefully considered the potential environmental impacts of the proposed action and at this time has made a preliminary determination that this action would not have a significant effect on the quality of the human environment in the United States.”

Read the entire article here

 

Be the first to comment on "FDA: Genetically modified salmon may be approved in 2013"

Leave a Reply